InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ho Maykin, Director. Insider active across 4 companies, notably Biomarin Pharmaceutical INC. Aggregated, 9 disclosures have been recorded. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
015,777 shares0
Common Stock
SEC:0001209191-22-038616:0·
04,980 shares0
Common Stock
SEC:0001567619-22-011792:0·
01,585 shares0
Common stock
SEC:0001439222-22-000050:0·
01,686 shares0
Common stock
SEC:0001439222-21-000049·
01,686 shares0
Common stock
SEC:0001439222-21-000049:0·
04,700 shares0
Common Stock
SEC:0001209191-21-036678·
04,700 shares0
Common Stock
SEC:0001209191-21-036678:0·
05,120 shares0
Common Stock
SEC:0001567619-21-011306·
05,120 shares0
Common Stock
SEC:0001567619-21-011306:0·
9 of 9 declarations
About Ho Maykin
Maykin Ho is a Board Member at Biomarin Pharmaceutical Inc, FibroGen Inc, and Agios Pharmaceuticals, Inc. She contributes to the governance of these companies by bringing her expertise to guide strategic decisions.
